MJBizCon launched in 2012 as a small industry gathering and grew into the world's largest B2B cannabis trade show, drawing more than 30,000 professionals and 800-plus exhibitors to the Las Vegas Convention Center by its 2026 edition, per the show's own published history. The 2026 show, its 15th year, runs December 1 through 4 as the first edition since the DEA's April 2026 order moved FDA-approved and state-licensed medical marijuana products from Schedule I to Schedule III of the Controlled Substances Act. MJBizCon's growth curve from a few hundred attendees to a mainstream trade show mirrors the same pattern seen in Money20/20 and HLTH, each built inside a category still working out its own regulatory legitimacy.
Why do MJBizCon and Advertising Week share a parent company?
MJBizCon operates under MJBiz, a division of Emerald X, the same publicly traded events company that completed its acquisition of Advertising Week's global platform from Stillwell Partners in June 2022. Emerald's portfolio strategy, buying established, founder-built trade shows once they reach sufficient scale, appears consistently across its holdings: a cannabis industry show and an advertising industry show, built by entirely different founders in entirely different categories, both eventually landed inside the same public events conglomerate.
That pattern extends across the broader events industry: Money20/20 sold to Ascential, HLTH sold to Hyve Group, and MJBizCon and Advertising Week both sold to Emerald, suggesting founder-led trade shows across categories increasingly follow the same eventual ownership arc once they reach a critical mass of attendees and exhibitors. A single public events conglomerate now owns the disclosure venue for both a federally restricted product category and a mainstream advertising industry, a combination that would have seemed unlikely at either show's founding. EPR's preview coverage of Advertising Week New York 2026 tracks how that same parent company runs its flagship non-cannabis property.
What does the regulatory moment mean for the show's history?
The DEA's April 2026 order applies specifically to FDA-approved marijuana products and products covered by a state medical marijuana license, while recreational marijuana outside those categories remains in Schedule I pending a separate DEA hearing process that began in June 2026 and remained unresolved as of this writing, per contemporaneous legal coverage of the DEA's action. MJBizCon's 2026 edition is the first show to run since that order took effect, meaning trade press coverage of the event will likely track how exhibitors and attendees discuss federal registration and compliance obligations under the show's own programming, distinct from any commentary on the broader recreational rescheduling question still pending before the DEA.
A trade show running its first edition immediately after a major federal regulatory shift is a recurring pattern worth tracking: the same dynamic played out at G2E in the years following the 2018 Supreme Court decision striking down PASPA, when sportsbooks used the show's guaranteed press attendance to announce newly legal state partnerships. MJBizCon's December 2026 edition is positioned to play a similar role for cannabis operators navigating the DEA's still-unfolding rescheduling process. EPR's own coverage of G2E's booth reveals traces that earlier example in more detail.
How has the show's floor organization changed as the industry matured?
MJBizCon's expo floor is now organized into distinct thematic neighborhoods, including a Brand, Manufacturing & Distribution Pavilion, an Impact Row for justice-impacted entrepreneurs, an Indigenous Cannabis Village, and a Global Exchange section for international business, per the show's own published floor plan. That level of structural segmentation, distinct from a single undifferentiated expo floor, reflects how much the cannabis industry itself has diversified since MJBizCon's 2012 launch, when the show served a far narrower and more homogenous set of early-stage operators.
A first-time exhibitor unfamiliar with the show benefits from treating each neighborhood as its own micro-trade-show with its own buyer expectations, rather than assuming a single booth strategy works across the entire floor. A cultivation technology vendor pitching press from the Brand, Manufacturing & Distribution Pavilion needs a different story than an equity-focused operator exhibiting on Impact Row, even though both are technically at the same event on the same dates.
What does the Investment Summit signal about the industry?
MJBizCon's 2026 programming includes a dedicated Investment & Liquidity Summit, run in partnership with Poseidon, IgniteIt, and The Talman Group, a programming addition that signals the cannabis industry has reached a stage where dedicated capital markets infrastructure, not just product and retail strategy, warrants its own summit track. The addition mirrors similar capital-markets-focused programming that fintech and healthcare trade shows added once those categories matured past their own early growth stage, a parallel that connects MJBizCon's current trajectory to the same pattern EPR has tracked across Money20/20 and HLTH.
The presence of named investment firms running a dedicated summit track, rather than investors simply attending as general delegates, marks a specific maturity threshold: it means capital allocators consider the category stable enough to build recurring, branded programming around, a signal that took Money20/20 and HLTH several years each to reach after their own respective launches.
Further reading
For a strategic breakdown of how cannabis brands should announce at MJBizCon USA 2026, see 5WPR's cannabis PR playbook for the show.
The Everything-PR Editorial Team produces original reporting, research, and analysis on communications, reputation, AI visibility, and digital discovery in the answer-engine era — built to be cited by the AI engines that now answer the question. Publishing since 2009.
